These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 10571082
21. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6). Cheung YF, Kan Z, Garrett-Engele P, Gall I, Murdoch H, Baillie GS, Camargo LM, Johnson JM, Houslay MD, Castle JC. J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386 [Abstract] [Full Text] [Related]
22. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ. Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):10909-13. PubMed ID: 7479908 [Abstract] [Full Text] [Related]
23. Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. Sasaki T, Kotera J, Omori K. Biochem J; 2002 Jan 15; 361(Pt 2):211-20. PubMed ID: 11772393 [Abstract] [Full Text] [Related]
24. The Two Isoforms of Lyn Display Different Intramolecular Fuzzy Complexes with the SH3 Domain. Teixeira JMC, Fuentes H, Bielskutė S, Gairi M, Żerko S, Koźmiński W, Pons M. Molecules; 2018 Oct 23; 23(11):. PubMed ID: 30360468 [Abstract] [Full Text] [Related]
25. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains. Chan DC, Bedford MT, Leder P. EMBO J; 1996 Mar 01; 15(5):1045-54. PubMed ID: 8605874 [Abstract] [Full Text] [Related]
26. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3). He R, Komas N, Ekholm D, Murata T, Taira M, Hockman S, Degerman E, Manganiello VC. Cell Biochem Biophys; 1998 Mar 01; 29(1-2):89-111. PubMed ID: 9631240 [Abstract] [Full Text] [Related]
27. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases. Zhang KY, Card GL, Suzuki Y, Artis DR, Fong D, Gillette S, Hsieh D, Neiman J, West BL, Zhang C, Milburn MV, Kim SH, Schlessinger J, Bollag G. Mol Cell; 2004 Jul 23; 15(2):279-86. PubMed ID: 15260978 [Abstract] [Full Text] [Related]
28. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, Bolger GB, Perry MJ, Owens RJ, Houslay MD. Biochem J; 1997 Dec 01; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714 [Abstract] [Full Text] [Related]
29. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. McPhee I, Pooley L, Lobban M, Bolger G, Houslay MD. Biochem J; 1995 Sep 15; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434 [Abstract] [Full Text] [Related]
30. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain. Gouri BS, Swarup G. Indian J Biochem Biophys; 1997 Sep 15; 34(1-2):29-39. PubMed ID: 9343926 [Abstract] [Full Text] [Related]
31. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue. Richter W, Jin SL, Conti M. Biochem J; 2005 Jun 15; 388(Pt 3):803-11. PubMed ID: 15717866 [Abstract] [Full Text] [Related]
32. Developmental regulation of unique adenosine 3',5'-monophosphate-specific phosphodiesterase variants during rat spermatogenesis. Naro F, Zhang R, Conti M. Endocrinology; 1996 Jun 15; 137(6):2464-72. PubMed ID: 8641200 [Abstract] [Full Text] [Related]
33. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain. Iona S, Cuomo M, Bushnik T, Naro F, Sette C, Hess M, Shelton ER, Conti M. Mol Pharmacol; 1998 Jan 15; 53(1):23-32. PubMed ID: 9443929 [Abstract] [Full Text] [Related]
34. Identification and kinetic analysis of the interaction between Nck-2 and DOCK180. Tu Y, Kucik DF, Wu C. FEBS Lett; 2001 Mar 02; 491(3):193-9. PubMed ID: 11240126 [Abstract] [Full Text] [Related]
35. Crystal structure of phosphodiesterase 4D and inhibitor complex(1). Lee ME, Markowitz J, Lee JO, Lee H. FEBS Lett; 2002 Oct 23; 530(1-3):53-8. PubMed ID: 12387865 [Abstract] [Full Text] [Related]
36. Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases. Monteiro AN. Biochimie; 2006 Jul 23; 88(7):905-11. PubMed ID: 16546311 [Abstract] [Full Text] [Related]
37. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Erdogan S, Houslay MD. Biochem J; 1997 Jan 01; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416 [Abstract] [Full Text] [Related]
38. Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo. Briggs SD, Lerner EC, Smithgall TE. Biochemistry; 2000 Jan 25; 39(3):489-95. PubMed ID: 10642173 [Abstract] [Full Text] [Related]
39. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Houslay MD, Baillie GS, Maurice DH. Circ Res; 2007 Apr 13; 100(7):950-66. PubMed ID: 17431197 [Abstract] [Full Text] [Related]
40. Investigation of the relationship between protein-protein interaction and catalytic activity of a heme-regulated phosphodiesterase from Escherichia coli (Ec DOS) by protein microarray. Sasakura Y, Kanda K, Yoshimura-Suzuki T, Matsui T, Fukuzono S, Shimizu T. Biochemistry; 2005 Jul 19; 44(28):9598-605. PubMed ID: 16008345 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]